MORRISVILLE, N.C. - May 6, 2020 - (Newswire.com)
Rita King, CEO and Senior Consultant of MethodSense, Inc., a medical device consulting firm, will serve as a panelist for a presentation co-hosted by NC LaunchBio and the North Carolina Biotechnology Center as part of their free Larger than Life Science event series on Wednesday, May 13, 2020, from 4:00-5:00 p.m. EDT via the Zoom platform.
Medical device companies responded to the COVID-19 outbreak by modifying existing technologies to help patients and clinicians impacted by the pandemic; others have found ways to meet virtually with doctors, regulators and university tech transfer offices. This event features experienced CEOs leading their teams during the pandemic crisis now and anticipating the eventual easing of restrictions across the country. The discussion will include insights into the impact of telemedicine on the industry, and what hospitals, insurers and investors are prioritizing for innovation and patient care.
King has served as a regulator, technologist and professional auditor for over 26 years, garnering an international reputation as a regulatory expert, and has been a participant in numerous national and international committees to develop industry standards and regulations. A founding member of the Underwriters Laboratories team that defined, launched and managed the operations of the first U.S. program to evaluate safety-critical software used in commercial and medical devices, King also contributed to the development of the ANSI (American National Standard Institute) approved Standard for Safety Critical Software, UL 1998.
Recently, King led the Methodsense effort to launch the EUA Resource Site to support those in the medical device community wanting to submit device authorization requests under the FDA Emergency Use Authorization Guidance.
"This resource combines our 20 years of compliance proficiency with numerous experts in the medical device field to answer questions about the EUA Authorization process," said King.
"During the COVID-19 crisis, MethodSense has led numerous companies and their medical device products through the FDA Emergency Use Authorization (EUA) process. Many of these clients are new to the medical device industry and must become medical device companies almost overnight. Most of these clients are looking beyond the EUA to become traditional medical device companies.
"We always work hard to make both the companies and people we work with better at what they do because of their experience with us," King said.
MethodSense, a medical device and combination product consulting firm, works with manufacturers, inventors and investors around the world to bring products to market and achieve business success in the U.S., E.U., Canada and other markets. Unmatched regulatory expertise and our purpose-built LuminLogic software platform uniquely position MethodSense to develop effective strategies for quality compliance and regulatory submissions, from initial filing to product launch and on-going quality and regulatory support. MethodSense has the answers. www.methodsense.com
###
Contact:
Russ King, President
O: 919.313.3962}
C: 919.607.4775
email: rking@methodsense.com
www.methodsense.com
Press Release Service by Newswire.com
Original Source: MethodSense CEO Selected as Panelist for Larger Than Life Science Event
